"Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus", published in /Viruses/ is being featured on the /Viruses/ Announcement
(https://www.mdpi.com/journal/viruses/announcements/7362) as a "Highly Cited Paper" as defined by Clarivate Essential Science Indicators.
/Highly Cited Papers/ are articles received enough citations to place them in the top 1% of the academic field of microbiology based on a highly cited threshold for the field and publication year.
Congratulations on your article being recognized as a "/Highly Cited Paper/." I invite you to share this great new s with your co-authors and colleagues.
